KoBioLabs

KoBioLabs CapEx/OCF

The CapEx to Operating Cash Flow Ratio of KoBioLabs (348150.KQ) as of Nov 16, 2026 is -9.56 %. In the previous year, CapEx to Operating Cash Flow Ratio was -37.80 % — a change of -74.71% (higher).

CapEx/OCF

-9.56 %

YoY

-74.71%

Last updated:

CapEx to Operating Cash Flow Ratio of KoBioLabs is 2025 -9.56 % . CapEx to Operating Cash Flow Ratio of KoBioLabs was 2024 -37.80 % . It decreases by -74.71% higher compared to the previous year.

The KoBioLabs CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
-14.92 KRW
Jan 1, 2019
-5.08 KRW
Jan 1, 2020
-0.98 KRW
Jan 1, 2021
-44.48 KRW
Jan 1, 2022
-89.18 KRW
Jan 1, 2023
-112.50 KRW
Jan 1, 2024
-37.80 KRW
Jan 1, 2025
-9.56 KRW
The KoBioLabs CapEx/OCF history
YEARCapEx/OCFYoY
-9.56 %-74.71%
-37.80 %-66.40%
-112.50 %+26.15%
-89.18 %+100.50%
-44.48 %+4,444.90%
-0.98 %-80.74%
-5.08 %-65.93%
-14.92 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

KoBioLabs Stock analysis

What does KoBioLabs do? KoBioLabs Inc., headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company focuses on research and development of the microbiome, developing products such as Bioviom and Queens henna FOODOLOGY, as well as new microbiome drugs. It provides commissioned research services and sells its products domestically and internationally. Listed on 18 November 2020, KoBioLabs is active in both domestic and overseas markets. KoBioLabs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KoBioLabs stock

CapEx to Operating Cash Flow Ratio of KoBioLabs is -9.56 % in 2025.

CapEx to Operating Cash Flow Ratio of KoBioLabs changed from -37.80 % to -9.56 %, representing a -74.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio KoBioLabs since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's KoBioLabs with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — KoBioLabs

All Key Metrics — KoBioLabs